AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20472590 — intervention group
Group type: EXPERIMENTAL
Intervention: Late season skim milk
Number of subjects: 16
Study 20472590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltrated MPC 85 skim milk
Number of subjects: 16
Study 20472590 — intervention group
Group type: COMPARATOR
Intervention: Soy control
Number of subjects: 16
Study 18822453 — intervention group
Group type: EXPERIMENTAL
Intervention: 1997 Partin tables
Number of subjects: 271
Study 18822453 — intervention group
Group type: COMPARATOR
Intervention: 2001 Partin tables
Number of subjects: 271
Study 15904499 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cardiac rehabilitation programme
Number of subjects: 1997
Study 15904499 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based cardiac rehabilitation programme
Number of subjects: 1997
Study 12528578 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) in high support sitting
Number of subjects: 7
Study 12528578 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) in left side‐lying
Number of subjects: 7
Study 12528578 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged basal expansion (SBE) in high support sitting
Number of subjects: 7
Study 12528578 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged basal expansion (SBE) in left side‐lying
Number of subjects: 7
Study 12528578 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation (PNF) and SBE in high support sitting and left side‐lying
Number of subjects: 7
Study 11218894 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: 10% glucose 500 ml + danshen compound 14 ml + low molecular weight dextran 500 ml i.v.
Number of subjects: 39
Study 11218894 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2: 10% glucose 500 ml + danshen compound 14 ml + low molecular weight dextran 500 ml i.v. + 25% magnesium sulfate 20 ml in 5% glucose 500 ml i.v.
Number of subjects: 39
Study 11218894 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3: no treatment given.
Number of subjects: 39
Study 11218894 — intervention group
Group type: COMPARATOR
Intervention: Control group: 12 normal term delivery women.
Number of subjects: 39
Study 9352146 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-practitioner using a computer decision-support system (CDSS) in group A (therapeutic range 2-3)
Number of subjects: 177
Study 9352146 — intervention group
Group type: COMPARATOR
Intervention: Trainee doctors (clinicians) in group A (therapeutic range 2-3)
Number of subjects: 177
Study 9352146 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-practitioner using a computer decision-support system (CDSS) in group B (therapeutic range 3-4.5)
Number of subjects: 177
Study 9352146 — intervention group
Group type: COMPARATOR
Intervention: Trainee doctors (clinicians) in group B (therapeutic range 3-4.5)
Number of subjects: 177
Study 8458057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 2.5 mg once daily
Number of subjects: 58
Study 8458057 — intervention group
Group type: COMPARATOR
Intervention: Placebo 2.5 mg once daily
Number of subjects: 58
Study 2957124 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper arm injection of 20 micrograms LHRH
Number of subjects: 9
Study 2957124 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower abdominal wall injection of 20 micrograms LHRH
Number of subjects: 9
Study 2957124 — intervention group
Group type: COMPARATOR
Intervention: Order of injections (upper arm first vs lower abdominal wall first)
Number of subjects: 9
Study 31513453 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (Femar®/Femara®)
Number of subjects: 0
Study 31513453 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane (Aromasin®)
Number of subjects: 0
Study 31513453 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 28577666 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month dual antiplatelet therapy (DAPT) after Resolute Integrity stent implantation
Number of subjects: 1100
Study 28577666 — intervention group
Group type: COMPARATOR
Intervention: 12-month dual antiplatelet therapy (DAPT)
Number of subjects: 1100
Study 24761812 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally sensitive health education intervention for Latina mothers
Number of subjects: 0
Study 24761812 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 23801158 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncotype DX testing
Number of subjects: 951
Study 21807330 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based gymnastic exercises (CHFw)
Number of subjects: 48
Study 21807330 — intervention group
Group type: COMPARATOR
Intervention: Land-based training (CHFl)
Number of subjects: 48
Study 19027814 — intervention group
Group type: EXPERIMENTAL
Intervention: Trilucent breast implants (TBI)
Number of subjects: 47
Study 19027814 — intervention group
Group type: COMPARATOR
Intervention: Reference group (REBI)
Number of subjects: 47
Study 16436822 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional MR imaging during deception (lie-only condition)
Number of subjects: 11
Study 16436822 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional MR imaging during truth telling (truth-only condition)
Number of subjects: 11
Study 16436822 — intervention group
Group type: COMPARATOR
Intervention: Polygraph examination for deceptive subjects
Number of subjects: 11
Study 16436822 — intervention group
Group type: COMPARATOR
Intervention: Polygraph examination for truthful subjects
Number of subjects: 11
Study 15522471 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 7599
Study 15522471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7599
Study 11243557 — intervention group
Group type: EXPERIMENTAL
Intervention: New goniometric technique
Number of subjects: 30
Study 11243557 — intervention group
Group type: COMPARATOR
Intervention: Traditional forearm passive range‐of‐motion goniometry
Number of subjects: 30
Study 9476456 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-term small-for-gestational age (SGA) neonates
Number of subjects: 25
Study 9476456 — intervention group
Group type: COMPARATOR
Intervention: Term appropriate-for-gestational age (AGA) neonates
Number of subjects: 25
Study 8200567 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined sclerotherapy (short term followed by longterm)
Number of subjects: 106
Study 8200567 — intervention group
Group type: COMPARATOR
Intervention: Short term sclerotherapy only
Number of subjects: 106
Study 3584738 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic acid (23 g/d for 4 weeks)
Number of subjects: 17
Study 3584738 — intervention group
Group type: COMPARATOR
Intervention: Oleic acid (23 g/d for 4 weeks)
Number of subjects: 17
Study 29669883 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (400 mg, twice daily for 48 weeks)
Number of subjects: 84
Study 28854973 — intervention group
Group type: EXPERIMENTAL
Intervention: CCH 0.40 mg
Number of subjects: 74
Study 28854973 — intervention group
Group type: EXPERIMENTAL
Intervention: CCH 0.60 mg
Number of subjects: 74
Study 28854973 — intervention group
Group type: EXPERIMENTAL
Intervention: CCH 0.25 mg
Number of subjects: 74
Study 28854973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 28854973 — intervention group
Group type: EXPERIMENTAL
Intervention: CCH (all doses)
Number of subjects: 74
Study 28854973 — intervention group
Group type: EXPERIMENTAL
Intervention: CCH 0.40 mg and 0.60 mg
Number of subjects: 74
Study 25456890 — intervention group
Group type: EXPERIMENTAL
Intervention: ToM training
Number of subjects: 72
Study 25456890 — intervention group
Group type: COMPARATOR
Intervention: Physical‐conversation training
Number of subjects: 72
Study 25456890 — intervention group
Group type: COMPARATOR
Intervention: Social-contact group
Number of subjects: 72
Study 23977864 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with blueberries (150 g on exercise days)
Number of subjects: 26
Study 23977864 — intervention group
Group type: COMPARATOR
Intervention: Exercise without blueberries (control)
Number of subjects: 26
Study 21263103 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) program, 20 two-hour sessions over 1 year, median attendance 85%
Number of subjects: 362
Study 18073232 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention (n = 101)
Number of subjects: 265
Study 18073232 — intervention group
Group type: COMPARATOR
Intervention: Normal weight children (control group)
Number of subjects: 265
Study 16864814 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaglinide
Number of subjects: 156
Study 16864814 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 156
Study 12755536 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone-coated cellulose (SCC) 800 mL
Number of subjects: 40
Study 12755536 — intervention group
Group type: COMPARATOR
Intervention: Water 800 mL
Number of subjects: 40
Study 10690940 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/d
Number of subjects: 27
Study 10690940 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 27
Study 9124991 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (P/T)
Number of subjects: 15
Study 9124991 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (P/T) alone
Number of subjects: 15
Study 7662242 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg once daily, titrated to 100 mg if blood pressure uncontrolled after 6 weeks
Number of subjects: 202
Study 7662242 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg once daily, titrated to 100 mg if blood pressure uncontrolled after 6 weeks
Number of subjects: 202
Study 7662242 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 202
Study 7662242 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 202
Study 7662242 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 202
Study 2501722 — intervention group
Group type: EXPERIMENTAL
Intervention: K-Sol
Number of subjects: 99
Study 2501722 — intervention group
Group type: COMPARATOR
Intervention: CSM (chondroitin sulfate corneal storage medium)
Number of subjects: 99
Study 2501722 — intervention group
Group type: COMPARATOR
Intervention: CSM
Number of subjects: 99
Study 267314 — intervention group
Group type: EXPERIMENTAL
Intervention: Apernyl
Number of subjects: 96
Study 267314 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 96
Study 31929469 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT (High-Intensity Interval Training)
Number of subjects: 50
Study 31929469 — intervention group
Group type: COMPARATOR
Intervention: No-exercise control
Number of subjects: 50
Study 28831250 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Daoyin (PD) program, 3-month, ten times-weekly supervised rehabilitation
Number of subjects: 464
Study 28831250 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary Daoyin (PD) program
Number of subjects: 464
Study 28831250 — intervention group
Group type: COMPARATOR
Intervention: Regular medical treatment (Control)
Number of subjects: 464
Study 26856013 — intervention group
Group type: EXPERIMENTAL
Intervention: O'Nano toothbrush
Number of subjects: 40
Study 26856013 — intervention group
Group type: COMPARATOR
Intervention: Oral-B Indicator 40 toothbrush
Number of subjects: 40
Study 26856013 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both brushes
Number of subjects: 40
Study 25112010 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (200 microg) in PCIA with fentanyl and tropisetron
Number of subjects: 91
Study 25112010 — intervention group
Group type: COMPARATOR
Intervention: Control group without dexmedetomidine in PCIA
Number of subjects: 91
Study 25112010 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (200 microg) in PCIA
Number of subjects: 91
Study 21782353 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency participants (employment-based reinforcement)
Number of subjects: 38
Study 21782353 — intervention group
Group type: COMPARATOR
Intervention: Prescription participants (standard care)
Number of subjects: 38
Study 21782353 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Contingency and Prescription)
Number of subjects: 38
Study 18972123 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with paclitaxel (200 mg/m²) and cisplatin (100 mg/m²)
Number of subjects: 71
Study 18972123 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by radiotherapy (69.9 Gy in 5.5 weeks)
Number of subjects: 71
Study 18972123 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy followed by radiotherapy
Number of subjects: 71
Study 18972123 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy
Number of subjects: 71
Study 17140398 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (4 sessions of 2-min contractions at 30% of maximal effort, 3 times per week for 8 weeks)
Number of subjects: 11
Study 17140398 — intervention group
Group type: COMPARATOR
Intervention: Non-exercised arm (internal control)
Number of subjects: 11
Study 16297751 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced inhalation anesthesia (BAL)
Number of subjects: 50
Study 16297751 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anesthesia
Number of subjects: 50
Study 11980997 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose radiation therapy (50.4 Gy/28 fractions)
Number of subjects: 203
Study 11980997 — intervention group
Group type: COMPARATOR
Intervention: High-dose radiation therapy (64.8 Gy/36 fractions)
Number of subjects: 203
Study 9719019 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 8100
Study 9719019 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 8100
Study 8916993 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 4033
Study 1663089 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral itraconazole for a period of 6-8 weeks
Number of subjects: 24
Study 1663089 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 7078717 — intervention group
Group type: COMPARATOR
Intervention: Neutral, emotionally loaded, and 'mental task' stimuli; specific details on dosage and duration not available.
Number of subjects: 0
Study 31641767 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral antibiotics (ciprofloxacin)
Number of subjects: 152
Study 31641767 — intervention group
Group type: COMPARATOR
Intervention: Intravenous antibiotics (ceftriaxone)
Number of subjects: 152
Study 30893483 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaflet intervention
Number of subjects: 3003
Study 30893483 — intervention group
Group type: EXPERIMENTAL
Intervention: Film intervention
Number of subjects: 3003
Study 30893483 — intervention group
Group type: COMPARATOR
Intervention: No information
Number of subjects: 3003
Study 28118256 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy plus amitriptyline (CBT+A)
Number of subjects: 135
Study 28118256 — intervention group
Group type: COMPARATOR
Intervention: Headache education plus amitriptyline (HE+A)
Number of subjects: 135
Study 26051874 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 50 mg alone for 5 days
Number of subjects: 40
Study 26051874 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin 10 mg coadministered with pioglitazone 45 mg for 7 days
Number of subjects: 40
Study 26051874 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin 25 mg coadministered with pioglitazone 45 mg for 7 days
Number of subjects: 40
Study 26051874 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin 50 mg coadministered with pioglitazone 45 mg for 7 days
Number of subjects: 40
Study 26051874 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin and pioglitazone combination treatment
Number of subjects: 40
Study 26051874 — intervention group
Group type: COMPARATOR
Intervention: Pioglitazone 45 mg alone for 7 days
Number of subjects: 40
Study 26051874 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin 10 mg coadministered with pioglitazone
Number of subjects: 40
Study 26051874 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin 25 mg coadministered with pioglitazone
Number of subjects: 40
Study 26051874 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin 50 mg coadministered with pioglitazone
Number of subjects: 40
Study 23538044 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtibial technique
Number of subjects: 53
Study 23538044 — intervention group
Group type: EXPERIMENTAL
Intervention: Anteromedial portal technique
Number of subjects: 53
Study 21735753 — intervention group
Group type: EXPERIMENTAL
Intervention: MK-0507A
Number of subjects: 474
Study 21735753 — intervention group
Group type: COMPARATOR
Intervention: timolol
Number of subjects: 474
Study 21735753 — intervention group
Group type: COMPARATOR
Intervention: concomitant therapy
Number of subjects: 474
Study 19704072 — intervention group
Group type: EXPERIMENTAL
Intervention: Training category 1 (core trainer)
Number of subjects: 4994
Study 19704072 — intervention group
Group type: EXPERIMENTAL
Intervention: Training category 2 (site trainer)
Number of subjects: 4994
Study 19704072 — intervention group
Group type: EXPERIMENTAL
Intervention: Training category 3 (expedited group)
Number of subjects: 4994
Study 19704072 — intervention group
Group type: EXPERIMENTAL
Intervention: All training methods combined
Number of subjects: 4994
Study 16714852 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose corticotropin stimulation test with 1 microg of 1-24 ACTH intravenously
Number of subjects: 100
Study 16714852 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreasing daily equipotent doses of inhaled corticosteroids
Number of subjects: 100
Study 16714852 — intervention group
Group type: COMPARATOR
Intervention: Control group (40 age-matched controls)
Number of subjects: 100
Study 15232700 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-s feedback schedule
Number of subjects: 18
Study 15232700 — intervention group
Group type: COMPARATOR
Intervention: 5-s feedback schedule
Number of subjects: 18
Study 15232700 — intervention group
Group type: COMPARATOR
Intervention: 20-s feedback schedule
Number of subjects: 18
Study 11310515 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination tablet (abacavir 300 mg, lamivudine 150 mg, zidovudine 300 mg taken twice/day)
Number of subjects: 12
Study 11310515 — intervention group
Group type: COMPARATOR
Intervention: ABC‐COM (abacavir 300 mg plus lamivudine 150 mg and zidovudine 300 mg taken twice/day)
Number of subjects: 12
Study 11310515 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combination tablet
Number of subjects: 12
Study 11310515 — intervention group
Group type: COMPARATOR
Intervention: ABC‐COM
Number of subjects: 12
Study 1296419 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium metabisulphite
Number of subjects: 7
Study 1296419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 6540986 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 22
Study 6540986 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 6540986 — intervention group
Group type: EXPERIMENTAL
Intervention: Dazoxiben
Number of subjects: 22
Study 31139691 — intervention group
Group type: EXPERIMENTAL
Intervention: Nusinersen treatment
Number of subjects: 151
Study 31139691 — intervention group
Group type: COMPARATOR
Intervention: Sham control treatment
Number of subjects: 151
Study 29250762 — intervention group
Group type: EXPERIMENTAL
Intervention: 40-degree warm saline irrigation
Number of subjects: 150
Study 29250762 — intervention group
Group type: COMPARATOR
Intervention: 20-25 degree saline irrigation (control)
Number of subjects: 150
Study 27490921 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of hydrocortisone (0.4-0.6 mg/kg body weight)
Number of subjects: 47
Study 24861159 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological therapy
Number of subjects: 14
Study 24861159 — intervention group
Group type: COMPARATOR
Intervention: Articulation therapy
Number of subjects: 14
Study 22572080 — intervention group
Group type: EXPERIMENTAL
Intervention: X6FFF photon beam
Number of subjects: 7
Study 22572080 — intervention group
Group type: EXPERIMENTAL
Intervention: X10FFF photon beam
Number of subjects: 7
Study 22572080 — intervention group
Group type: EXPERIMENTAL
Intervention: X10 photon beam
Number of subjects: 7
Study 22572080 — intervention group
Group type: COMPARATOR
Intervention: Flattened beams (X6, X10)
Number of subjects: 7
Study 22572080 — intervention group
Group type: EXPERIMENTAL
Intervention: FFF beams (X6FFF, X10FFF)
Number of subjects: 7
Study 20199367 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (group 1, 13 patients)
Number of subjects: 39
Study 20199367 — intervention group
Group type: EXPERIMENTAL
Intervention: No rituximab (group 2, 26 patients)
Number of subjects: 39
Study 20199367 — intervention group
Group type: COMPARATOR
Intervention: Healthy blood donors (control group)
Number of subjects: 39
Study 18827302 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-instructions combined with email contact
Number of subjects: 171
Study 18827302 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list condition
Number of subjects: 171
Study 15939139 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 5-fluorouracil and folinic acid plus carboplatin (standard administration)
Number of subjects: 37
Study 15939139 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with 5-fluorouracil and folinic acid plus carboplatin (chronomodulated administration)
Number of subjects: 37
Study 15939139 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with 5-fluorouracil and folinic acid (without carboplatin, standard administration)
Number of subjects: 37
Study 15939139 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with 5-fluorouracil and folinic acid (without carboplatin, chronomodulated administration)
Number of subjects: 37
Study 12847071 — intervention group
Group type: EXPERIMENTAL
Intervention: EH+
Number of subjects: 36
Study 12847071 — intervention group
Group type: EXPERIMENTAL
Intervention: EH-
Number of subjects: 36
Study 12847071 — intervention group
Group type: COMPARATOR
Intervention: NT
Number of subjects: 36